CYTOKINETICS INC (CYTK)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 40M 80M 120M FY09: 81.5M FY10: 2.6M FY11: 4M FY12: 7.6M FY13: 30.6M FY14: 46.9M FY15: 28.7M FY16: 106.4M FY17: 13.4M FY18: 31.5M FY19: 26.9M FY20: 55.8M FY21: 70.4M FY22: 94.6M FY23: 7.5M FY24: 18.5M FY25: 88M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Annual

-750M -500M -250M 0 250M 500M 750M FY09: 26.1M FY10: -49.6M FY11: -48M FY12: -40.5M FY13: -33.9M FY14: -14.8M FY15: -37.4M FY16: 18.7M FY17: -113.4M FY18: -88.9M FY19: -98.9M FY20: -93.9M FY21: -186.3M FY22: -324.2M FY23: -496.2M FY24: -536.2M FY25: -612.3M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-900M -600M -300M 0 300M 600M 900M FY99: -7.3M FY00: -13.1M FY01: -15.9M FY02: -23.1M FY03: -32.7M FY04: -37.2M FY05: -42.3M FY06: -57.1M FY07: -48.9M FY08: -56.4M FY09: 24.5M FY10: -49.3M FY11: -47.9M FY12: -40.4M FY13: -33.7M FY14: -14.6M FY15: -37.5M FY16: 16.5M FY17: -127.8M FY18: -106.3M FY19: -121.7M FY20: -127.3M FY21: -215.3M FY22: -389M FY23: -526.2M FY24: -589.5M FY25: -785M FY01 FY04 FY07 FY10 FY13 FY16 FY19 FY22 FY25

Cost of Revenue Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Annual

-600M -400M -200M 0 200M 400M 600M FY09: 8.4M FY10: -44.8M FY11: -45.6M FY12: -33.4M FY13: -7.7M FY14: -44.8M FY15: 4.9M FY16: 37M FY17: -101.8M FY18: -101.2M FY19: -90.9M FY20: 8.9M FY21: -142.5M FY22: -299.5M FY23: -414.3M FY24: -395.9M FY25: -510M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

-600M -400M -200M 0 200M 400M 600M FY09: 7.9M FY10: -45.3M FY11: -46M FY12: -33.6M FY13: -8.3M FY14: -45.9M FY15: 4.3M FY16: 35.4M FY17: -104.6M FY18: -102.1M FY19: -93.5M FY20: -2.1M FY21: -191.4M FY22: -310.9M FY23: -415.7M FY24: -399.8M FY25: -534.8M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 40M 80M 120M FY09: 58M FY10: 64.2M FY11: 70.8M FY12: 108.6M FY14: 35.7M FY15: 38.8M FY16: 42.6M FY17: 49.4M FY20: 64.5K FY21: 76.9K FY22: 89.8K FY23: 96.5K FY24: 112K FY25: 120.1K FY10 FY12 FY15 FY17 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-6.00 -4.00 -2.00 0.00 2.00 4.00 6.00 Q4 '10: -0.77 Q1 '11: -0.76 Q2 '11: -0.78 Q3 '11: -0.74 Q4 '11: -4.31 Q1 '12: -4.26 Q2 '12: -4.79 Q3 '12: -5.09 Q4 '12: -1.78 Q1 '13: -2.18 Q2 '13: -2.00 Q3 '13: -1.98 Q4 '13: -1.24 Q1 '14: -0.98 Q2 '14: -0.63 Q3 '14: -0.36 Q4 '14: -0.41 Q1 '15: -0.37 Q2 '15: -0.41 Q3 '15: -0.48 Q4 '15: -0.97 Q1 '16: -1.05 Q2 '16: -1.07 Q3 '16: -0.07 Q4 '16: 0.33 Q1 '17: 0.02 Q2 '17: -0.29 Q3 '17: -1.66 Q4 '17: -2.59 Q1 '18: -2.53 Q2 '18: -2.44 Q3 '18: -2.24 Q4 '18: -1.95 Q1 '19: -1.93 Q2 '19: -1.98 Q3 '19: -2.08 Q4 '19: -2.11 Q1 '20: -2.23 Q2 '20: -2.35 Q3 '20: -1.90 Q4 '20: -2.02 Q1 '21: -2.02 Q1 '12 Q3 '13 Q1 '15 Q3 '16 Q1 '18 Q3 '19 Q1 '21

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.